| | | Orthosiphol A
CAS:142741-25-1
Formula: C38H44O11
97%
NP1419
orthosiphol A; 142741-25-1; CHEMBL508620; SCHEMBL1990731; HIBFBUSEUDRQMX-OFUWLHILSA-; AKOS040762796; FS-8509; [(2R,4R,4aS,4bS,5R,6S,7S,8aS,10R,10aR)-6,10-diacetyloxy-5-benzoyloxy-2-ethenyl-7,10a-dihydroxy-2,4b,8,8-tetramethyl-1-oxo-4,4a,5,6 ORYZALEXIN E
CAS:162995-10-0
Formula: C20H32O2
BB058634
(2R,4aR,4bS,7S,10aR)-7-Ethenyl-2,3,4,4a,5,6,7,9,10,10a-decahydro-1,1,4a,7-tetramethyl-2,4b(1H)-phenanthrenediol Oseltamivir acid tartrate salt
CAS:1215211-48-5
Formula: C14H24N2O4.C4H6O6
GëÑ95%
1215211-48-5
(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid compound with 2,3-dihydroxysuccinic acid (1:1); 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R,4S,5S)-, (2S,3S)-2,3-dihydro OSELTAMIVIR CITRATE
CAS:209965-30-0
Formula: C16H28N2O4.C6H8O7
95%
209965-30-0
1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt); Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(3-pentanyloxy)-1-cyclohexene-1-carboxylate 2 OSELTAMIVIR GLUCOSE ADDUCT 1
Formula: C22H38N2O9
95%
Ethyl (3R,4R,5S)-4-acetamido-3-(pentan-3-yloxy)-5-(((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)amino)cyclohex-1-ene-1-carboxylate; (3R,4R,5S)-Ethyl 4-acetamido-3-(pentan-3-yloxy)-5-(((2R,3R,4S,5S,6R)-3,4,5-t OSTEOSTATIN (1-5) (HUMAN, BOVINE, DOG, HORSE, MOUSE, RABBIT, RAT)
CAS:138949-73-2
Formula: C27H41N9O8
BAT-015912
(6S,9S,12S,15S)-15-((1H-indol-3-yl)methyl)-1-amino-6-((2S,3R)-2-amino-3-hydroxybutanamido)-9-(hydroxymethyl)-1-imino-12-methyl-7,10,13-trioxo-2,8,11,14-tetraazahexadecan-16-oic acid; pTH-rP (107-111) (human, bovine, dog, horse, mouse, rabbi OTAPLIMASTAT
CAS:1176758-04-5
Formula: C28H34N6O5
GëÑ95%
1176758-04-5
SP-8203; Acetamide, N-[3-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)propyl]-N-[4-[[3-(1,4-dihydro-2,4-dioxo-3(2H)-quinazolinyl)propyl]amino]butyl]-; N-(3-(1,2,3,4-Tetrahydro-2,4-dioxoquinazoline-3-yl)propyl)-N-(4-((3-(1,2,3,4-tetrahydro-2,4- OTOPHYLLOSIDE F
CAS:250217-73-3
Formula: C48H76O16
95.0%
NP6177
Otophylloside F; 250217-73-3; [(3S,8S,9R,10R,12R,13S,14R,17S)-17-acetyl-8,14,17-trihydroxy-3-[(2R,4S,5S,6R)-4-hydroxy-5-[(2S,4S,5R,6R)-5-[(2S,4R,5R,6R)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-6-methyloxan-2 OTX008
CAS:286936-40-1
Formula: C52H72N8O8
>98%
286936-40-1
Acetamide, 2,2',2'',2'''-[pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetrayltetrakis(oxy)]tetrakis[N-[2-(dimethylamino)ethyl]-.; OTX-008; OTX 008; OTX008; PTX008; PTX-008 OUABAIN OCTAHYDRATE
CAS:11018-89-6
Formula: C29H44O12.8H2O
>98%
11018-89-6
(1b,3b,5b,11a)-3-[(6-Deoxy-a-L-mannopyranosyl)oxy]-1,5,11,14,19-pentahydroxycard-20(22)-enolide octahydrate; g-Strophanthin octahydrate; Acocantherine; 1b,3b,5b,11a,14,19-Hexahydroxycard-20(22)-enolide 3-(6-deoxy-+¦-L-mannopyranoside) OXACILLIN PENILLIC ACID DISODIUM SALT (MIXTURE OF DIASTEREOMERS)
Formula: C19H17N3Na2O5S
80%
2,3,7,7a-Tetrahydro-2,2-dimethyl-5-(5-methyl-3-phenyl-4-isoxazolyl)-Imidazo[5,1-b]thiazole-3,7-dicarboxylic Acid Disodium Salt; Disodium 2,2-dimethyl-5-(5-methyl-3-phenyl-1,2-oxazol-4-yl)-2,3,7,7a-tetrahydroimidazo[5,1-b][1,3]thiazole-3,7-d Oxacyclohexane open ring tacrolimus
CAS:144432-23-5
Formula: C44H71NO13
GëÑ90% by HPLC
BBF-05769
Tacrolimus Open Ring Impurity; Tacrolimus related compound, tacrolimus open ring; 3H-Pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,19,21(4H,8H,12H,23H)-tetrone, 5,6,11,13,14,15,16,17,18,20,24,25,26,26a-tetradecahydro-5,15,20,20-tetrahydroxy-3- OXALIPLATIN
CAS:61825-94-3
Formula: C8H14N2O4Pt
>98%
B0084-095706
Platinum, [(1R,2R)-1,2-cyclohexanediamine-+¦N1,+¦N2][ethanedioato(2-)-+¦O1,+¦O2]-, (SP-4-2)-; (SP-4-2)-[(1R,2R)-1,2-Cyclohexanediamine-+¦N1,+¦N2][ethanedioato(2-)-+¦O1,+¦O2]platinum; 1,2-Cyclohexanediamine, platinum complex, (1R-trans)-; Platinum, OXCARBAZEPINE EP IMPURITY I
CAS:537693-29-1
Formula: C15H10N2O3
> 95%
B2694-477714
11-Keto Oxcarbazepine; 10,11-Dioxo-10,11-dihydro-5H-dibenzo(b,f)azepine-5-carboxamide; 5H-Dibenz(b,f)azepine-5-carboxamide, 10,11-dihydro-10,11-dioxo-; 10,11-Dioxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide; 10,11-Dihydro-10,11-diox OXETANE-3-BORONIC ACID PINACOL ESTER
CAS:1396215-84-1
Formula: C9H17O3B
BB008970
4,4,5,5-tetramethyl-2-(3-oxetanyl)-1,3,2-dioxaborolane; 4,4,5,5-tetramethyl-2-(oxetan-3-yl)-1,3,2-dioxaborolane OXIRANE, METHYL-, POLYMER WITH OXIRANE, MONO(3-(1,3,3,3-TETRAMETHYL-1-((TRIMETHYLSILYL)OXY)DISILOXANYL)PROPYL) ETHER
CAS:134180-76-0
Formula: C15H38O5Si3
98%
134180-76-0
Oxirane, methyl-, polymer with oxirane, mono3-1,3,3,3-tetramethyl-1-(trimethylsilyl)oxydisiloxanylpropyl ether; heptamethyltrisiloxane, ethoxylate,propoxylate allyl ether OXIRAPENTYN
CAS:88205-90-7
Formula: C18H20O6
BBF-02330
(3R,4aR)-3+¦-(Acetyloxy)-3,4,7a+¦,7b+¦-tetrahydro-2,2-dimethyl-6a+¦-(3-methyl-3-buten-1-ynyl)-2H,5a+¦H-bisoxireno[e,h]-1-benzopyran-6(6aH)-one; 2H,5aH-Bisoxireno[e,h]-1-benzopyran-6(6aH)-one, 3-(acetyloxy)tetrahydro-2,2-dimethyl-6a-(3-methyl-3-b OXIRENO[9,10]CYCLODECA[1,2-B]FURAN-9(1AH)-ONE,7-(ACETYLOXY)-2,3,6,7,7A,8,10A,10B-OCTAHYDRO- 1A,5-DIMETHYL-8-METHYLENE-,[1AR-(1AR*,4E,- 7R*,7AR*,10AS*,10BS*)]-
CAS:41059-80-7
Formula: C17H22O5
>98%
NP5613
(1aR,4E,7R,7aR,10aS,10bR)-7-Acetoxy-2,3,6,7,7a,8,10a,10b-octahydro-1a,5-dimethyl-8-methyleneoxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one; Lipiferolide; Oxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one,7-(acetyloxy)-2,3,6,7,7a,8,10a,10b-octahy OXOEPISTEPHAMIERSINE
CAS:51804-68-3
Formula: C21H25NO7
NP0184
Oxoepistephamiersine; 51804-68-3; (8R,10S,12S)-3,4,11,12-tetramethoxy-17-methyl-18-oxa-17-azapentacyclo[8.4.3.18,11.01,10.02,7]octadeca-2(7),3,5-triene-13,16-dioneAKOS032948720Hasubanan-6,16-dione, 8,10-epoxy-3,4,7,8-tetramethoxy-17-methyl- OXONIC ACID-[13C2,15N3] POTASSIUM SALT HYDRATE
Formula: C2[13C]2H2[15N]3KO4.H2O
95%
BLP-007846
1,4,5,6-Tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylic Acid-13C2,15N3 Potassium Salt Hydrate; Oxonic acid-13C2,15N3 potassium salt Hydrate; Triazine-2,4-dione-6-carboxylic Acid-13C2,15N3 Potassium Salt Hydrate; 5-Azaorotic Acid-13C2,15N3 OXOTREMORINE M IODIDE
CAS:3854-04-4
Formula: C11H19IN2O
GëÑ98% by HPLC
3854-04-4
2-Butyn-1-aminium, N,N,N-trimethyl-4-(2-oxo-1-pyrrolidinyl)-, iodide (1:1); 2-Butyn-1-aminium, N,N,N-trimethyl-4-(2-oxo-1-pyrrolidinyl)-, iodide; Ammonium, trimethyl[4-(2-oxo-1-pyrrolidinyl)-2-butynyl]-, iodide; Trimethyl[4-(2-oxo-1-pyrroli OXTRIPHYLLINE
CAS:4499-40-5
Formula: C12H21N5O3
GëÑ98%
4499-40-5
2-Hydroxy-N,N,N-trimethyl-ethanaminium salt with 3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione; 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dioneion(1-), 2-hydroxy-N,N,N-trimethylethanaminium; Oxyma-B
CAS:5417-13-0
Formula: C6H7N3O4
GëÑ95%
BB080151
2,4,5,6(1H,3H)-Pyrimidinetetrone, 1,3-dimethyl-, 5-oxime; 1,3-Dimethyl-2,4,5,6(1H,3H)-pyrimidinetetrone 5-oxime; Alloxan, 1,3-dimethyl-, 5-oxime; Alloxan, dimethyl-, 5-oxime; 1,3-Dimethylvioluric acid; Dimethylvioluric acid; N,N'-Dimethylvi OXYNITIDINE
CAS:548-31-2
Formula: C90H140N34O19S2
548-31-2
OXYNITIDINE;548-31-2;6-oxynitidine;2,3-dimethoxy-12-methyl-[1,3]benzodioxolo[5,6-c]phenanthridin-13-one;2,3-Dimethoxy-12-methyl-12H-[1,3]dioxolo-[4',5':4,5]benzo[1,2-c]phenanthridin-13-one;1WH82UJD2G;(1,3)Benzodioxolo(5,6-c)phenanthridin-13 OXYPHENCYCLIMINE
CAS:125-53-1
Formula: C20H28N2O3
98%
125-53-1
Benzeneacetic acid, +¦-cyclohexyl-+¦-hydroxy-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester; 2-Pyrimidinemethanol, 1,4,5,6-tetrahydro-1-methyl-, +¦-phenylcyclohexaneglycolate (ester); Cyclohexaneglycolic acid, +¦-phenyl-, (1,4,5,6-te OXYPHENCYCLIMINE HYDROCHLORIDE
CAS:125-52-0
Formula: C20H28N2O3.HCl
GëÑ99%
125-52-0
Benzeneacetic acid, +¦-cyclohexyl-+¦-hydroxy-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, hydrochloride (1:1); Benzeneacetic acid, +¦-cyclohexyl-+¦-hydroxy-, (1,4,5,6-tetrahydro-1-methyl-2-pyrimidinyl)methyl ester, monohydrochlori Oxytetracycline calcium (1:x)
CAS:15251-48-6
Formula: C22H24N2O9.xCa
15251-48-6
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, calcium salt, [4S-(4+¦,4a+¦,5+¦,5a+¦,6+¦,12a+¦)]-; Calcium oxytetracycline; (4S,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)-1,4 Oxytetracycline calcium (2:1)
CAS:13303-91-8
Formula: C44H46CaN4O18
GëÑ95%
13303-91-8
2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, calcium salt (2:1), (4S,4aR,5S,5aR,6S,12aS)-; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octa OXYTETRACYCLINE DIHYDRATE
CAS:6153-64-6
Formula: C22H24N2O9.2H2O
>98%
BBF-04558
[4S-(4+¦,4a+¦,5+¦,5a+¦,6+¦,12a+¦]-4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Dihydrate; 5-Hydroxytetracycline Dihydrate OXYTETRACYCLINE EP IMPURITY A
CAS:14206-58-7
Formula: C22H24N2O9
>95% by HPLC
BBF-04440
Oxytetracycline Impurity A; 4-Epioxytetracycline; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, (4R,4aR,5S,5aR,6S,12aS)-; [4R-(4+¦,4a+¦,5+¦,5a+¦,6+¦,12a+¦]-4-(Dimethyl OXYTETRACYCLINE EP IMPURITY C
CAS:7647-65-6
Formula: C23H25NO9
GëÑ95%
B2694-072460
2-Acetyl-2-decarbamoyloxytetracycline; Oxytetracycline Impurity C; Terramycin-X; 1,11(4H,5H)-Naphthacenedione, 2-acetyl-4-(dimethylamino)-4a,5a,6,12a-tetrahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-, (4S,4aR,5S,5aR,6S,12aS)-; (4S,4aR,5S,5aR OXYTETRACYCLINE EP IMPURITY D
CAS:18695-01-7
Formula: C22H22N2O8
>95% by HPLC
BBF-04355
(3S,4S,5S)-4-[(1R)-4,5-Dihydroxy-9-methyl-3-oxo-1,3-dihydronaphtho[2,3-c]furan-1-yl]-3-(dimethylamino)-2,5-dihydroxy-6-oxocyclohex-1-ene-1-carboxamide; 1-Cyclohexene-1-carboxamide, 4-[(1R)-1,3-dihydro-4,5-dihydroxy-9-methyl-3-oxonaphtho[2,3 OXYTETRACYCLINE EP IMPURITY E
CAS:18751-99-0
Formula: C22H22N2O8
>95% by HPLC
BBF-04361
(3S,4S,5R)-4-[(1R)-4,5-Dihydroxy-9-methyl-3-oxo-1,3-dihydronaphtho[2,3-c]furan-1-yl]-3-(dimethylamino)-2,5-dihydroxy-6-oxocyclohex-1-ene-1-carboxamide; 1-Cyclohexene-1-carboxamide, 4-[(3R)-1,3-dihydro-4,5-dihydroxy-9-methyl-3-oxonaphtho[2,3 OXYTETRACYCLINE EP IMPURITY F
CAS:4660-26-8
Formula: C22H22N2O8
GëÑ95%
4660-26-8
Anhydrooxytetracycline; 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,5,10,11,12a-pentahydroxy-6-methyl-1,12-dioxo-, (4S,4aR,5R,12aS)-; (4S,4aR,5R,12aS)-4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,5,10,11,12a-pen OXYTOCIN ACETATE
CAS:6233-83-6
Formula: C45H70N12O14S2
>98%
6233-83-6
(S)-N-((S)-1-((2-amino-2-oxoethyl)amino)-4-methyl-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16S,19R)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-((S)-sec-butyl)-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pe P-[(1R,2R)-1,2-DIHYDROXYPROPYL]PHOSPHONIC ACID BIS(PHENYLMETHYL) ESTER
Formula: C17H21O5P
Phosphonic acid, P-[(1R,2R)-1,2-dihydroxypropyl]-, bis(phenylmethyl) ester; [(1R,2R)-1,2-Dihydroxypropyl]phosphonic Acid Bis(phenylmethyl) Ester; Dibenzyl ((1R,2R)-1,2-dihydroxypropyl)phosphonate; [(1R,2R)-1,2-Dihydroxypropyl]phosphonic aci P-[2-(3,4-DIHYDRO-7-METHOXY-4,4-DIMETHYL-1,3-DIOXO-2(1H)-ISOQUINOLYL)ETHYL]BENZENESULPHONAMIDE
CAS:33456-68-7
Formula: C20H22N2O5S
95%
33456-68-7
Benzenesulfonamide, 4-[2-(3,4-dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]-; 4-[2-(3,4-Dihydro-7-methoxy-4,4-dimethyl-1,3-dioxo-2(1H)-isoquinolinyl)ethyl]benzenesulfonamide; Benzenesulfonamide, p-[2-(3,4-dihydro-7-met p-NCS-BZ-DOTA-GA
CAS:2194580-71-5
Formula: C27H38N6O9S
GëÑ90%
2194580-71-5
2,2',2''-(10-(1-carboxy-4-((4-isothiocyanatobenzyl)amino)-4-oxobutyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid; 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, +¦1-[3-[[(4-isothiocyanatophenyl)methyl]amino]-3-oxopr p-NHGéé-Bn-PCTA
CAS:2125661-64-3
Formula: C24H31N5O6
BB058662
3,6,9,15-Tetraazabicyclo[9.3.1] pentadeca-1(15),11,13-triene-4-S-(4-aminobenzyl)-3,6,9-triacetic acid; (4S)-4-[(4-aminophenyl)methyl]-3,6,9,15-Tetraazabicyclo[9.3.1]pentadeca-1(15),11,13-triene-3,6,9-triacetic acid p-Nitrophenyl 2-Acetamido-2-deoxy-3,6-di-O-acetyl-4-O-[2'-O-(2',3',4'-tri-O-benzoyl-+¦-L-fucopyranosyl)]-+¦-D-glucopyranoside
Formula: C45H44N2O17
(4-Nitrophenyl) 2,3,4-tri-O-benzoyl-6-deoxy-alpha-L-galacto-hexopyranosyl-(1->4)-2-acetamido-3,6-di-O-acetyl-2-deoxy-beta-D-gluco-hexopyranoside; (2S,3S,4R,5R,6S)-2-(((2R,3S,4R,5R,6S)-5-acetamido-4-acetoxy-2-(acetoxymethyl)-6-(4-nitrophenox p-Nitrophenyl 2-Acetamido-2-deoxy-3-O-[2'-O-(2,3,4-tri-O-benzoyl-+¦-L-fucopyranosyl)-3',4',6'-tri-O-acetyl-D-galactopyranosyl]-+¦-D-glucopyranoside
Formula: C53H56N2O23
(4-Nitrophenyl) 2,3,4-tri-O-benzoyl-6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-3,4,6-tri-O-acetyl-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-gluco-hexopyranoside; p-Nitrophenyl 2-Acetamido-2-deoxy-3-O-[2'-O-(2,3,4-tri- p-Nitrophenyl 2-Acetamido-2-deoxy-3-O-[2'-O-(2,3,4-tri-O-benzoyl-+¦-L-fucopyranosyl)-3',4',6'-tri-O-acetyl-D-galactopyranosyl]-6-O-trityl-+¦-D-glucopyranoside
Formula: C72H70N2O23
(4-Nitrophenyl) 2,3,4-tri-O-benzoyl-6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-3,4,6-tri-O-acetyl-beta-D-galacto-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-6-O-trityl-beta-D-gluco-hexopyranoside; (2S,3S,4R,5R,6S)-2-(((2R,3R,4S,5S,6R)-2-(((2 p-Nitrophenyl 2-Acetamido-6-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-+¦-D-glucopyranosyl)-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-+¦-D-galactopyranosyl)-+¦-D-galactopyranoside
Formula: C42H55N3O25
(4-Nitrophenyl) 2,3,4,6-tetra-O-acetyl-beta-D-galacto-hexopyranosyl-(1->3)-[2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-beta-D-gluco-hexopyranosyl-(1->6)]-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranoside; (2R,3R,4S,5S,6R)-2-(((2R,3R,4R,5R,6R)- p-Nitrophenyl 6-O-Benzoyl-2-O-(2,3,4-tri-O-acetyl-+¦-L-fucopyranosyl)-+¦-D-galactopyranoside
Formula: C31H35NO16
Fuc2Ac3Ac4Ac(a1-2)[Bz(-6)]Gal(a)-O-Ph(4-NO2); (4-Nitrophenyl) 2,3,4-tri-O-acetyl-6-deoxy-alpha-L-galacto-hexopyranosyl-(1->2)-6-O-benzoyl-alpha-D-galacto-hexopyranoside; (2S,3S,4R,5R,6S)-2-(((2R,3R,4S,5R,6R)-6-((Benzoyloxy)methyl)-4,5-dihyd p-Nitrophenyl Carbonate 2,3,4-Tri-O-acetyl-+¦-D-glucuronide Methyl Ester
CAS:228412-71-3
Formula: C20H21NO14
GëÑ98%
228412-71-3
+¦-D-Glucopyranuronic acid, methyl ester, 2,3,4-triacetate 1-(4-nitrophenyl carbonate); 4-Nitrophenoxycarbonyl 2,3,4-tri-O-acetyl-+¦-D-glucopyranuronic acid methyl ester; (2S,3S,4S,5R,6S)-2-(Methoxycarbonyl)-6-(((4-nitrophenoxy)carbonyl)oxy)t P-NO2-BN-DOTA
CAS:116052-88-1
Formula: C23H33N5O10
BB058656
(2S)-2-[(4-Nitrophenyl)methyl]-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic Acid; (S)-2-[(4-nitrophenyl)methyl]-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid; (S)NBD P-SCN-BN-DOTA
CAS:127985-74-4
Formula: C24H33N5O8S
98%
BADC-01403
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, 2-[(4-isothiocyanatophenyl)methyl]-; 2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid; 2,2',2'',2'''-[2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazac P-TOLYL 2,3,4-TRI-O-ACETYL-A-L-RHAMNOPYRANOSIDE
CAS:620951-70-4
Formula: C19H24O7S
GëÑ95%
620951-70-4
+¦-L-Mannopyranoside, 4-methylphenyl 6-deoxy-1-thio-, 2,3,4-triacetate; (2S,3S,4R,5R,6S)-2-Methyl-6-(p-tolylthio)tetrahydro-2H-pyran-3,4,5-triyl triacetate; 4-Methylphenyl 6-deoxy-1-thio-+¦-L-mannopyranoside 2,3,4-triacetate; +¦-L-Mannopyranos P-TOLYLBORONIC ACID PINACOL ESTER
CAS:195062-57-8
Formula: C13H19O2B
BB015103
4,4,5,5-tetramethyl-2-(4-methylphenyl)-1,3,2-dioxaborolane; 4,4,5,5-tetramethyl-2-(4-methylphenyl)-1,3,2-dioxaborolane P5 LIGAND FOR DNAK AND DNAJ
CAS:209518-24-1
Formula: C44H81N15O11S
GëÑ95%
BAT-009318
Peptide p5; H-Cys-Leu-Leu-Leu-Ser-Ala-Pro-Arg-Arg-OH; L-cysteinyl-L-leucyl-L-leucyl-L-leucyl-L-seryl-L-alanyl-L-prolyl-L-arginyl-L-arginine; 2-[(2S)-2-({[(2S)-1-{N-[(2S,5S,8S,11S,14R)-14-Amino-1,4,7,10,13-pentahydroxy-2-(hydroxymethyl)-5,8, PACHYSAMINE M
CAS:1253202-75-3
Formula: C28H44N2O2
97.0%
NP0679
Pachysamine M; 1253202-75-3; N-[(5R,8S,9S,10R,13S,14S,17S)-17-[(1S)-1-(dimethylamino)ethyl]-10,13-dimethyl-4-oxo-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-yl]-3-methylbut-2-enamide PACIDAMYCIN 5
CAS:122855-43-0
Formula: C36H44N8O11
BBF-02336
3,5,8,11-Tetraazatetradecanoicacid,13-amino-9-[[[(Z)-[(4R,5R)-5-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)dihydro-4-hydroxy-2(3H)-furanylidene]methyl]amino]carbonyl]-14-(3-hydroxyphenyl)-6,10,11-trimethyl-4,7,12-trioxo-2-(phenylmethyl)-, (2S PACLITAXEL D5
CAS:1129540-33-5
Formula: C47H46D5NO14
98% by CP; 98% atom D
BLP-003717
Paclitaxel-d5; [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-Diacetyloxy-1,9-dihydroxy-15-[(2R,3S)-2-hydroxy-3-[(2,3,4,5,6-pentadeuteriobenzoyl)amino]-3-phenylpropanoyl]oxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-1 PACLITAXEL EP IMPURITY G
CAS:78432-77-6
Formula: C45H49NO13
>98%
NP1508
4-(Acetyloxy)-13+¦-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,7+¦,10+¦-trihydroxy-9-oxo-5+¦,20-epoxytax-11-en-2+¦-yl benzoate; 10-O-Deacetylpaclitaxel; Benzenepropanoic acid, +¦-(benzoylamino)-+¦-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,1 PACLITAXEL EP IMPURITY L
CAS:92950-39-5
Formula: C49H53NO15
GëÑ95%
92950-39-5
4,7+¦,10+¦-tris(acetyloxy)-13+¦-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1-hydroxy-9-oxo-5+¦,20-epoxytax-11-en-2+¦-yl benzoate; 7-O-Acetylpaclitaxel; 7-Acetyl Paclitaxel; 7-Acetyltaxol; (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-4,6,12b- PACLITAXEL EP IMPURITY M
CAS:2850227-40-4
Formula: C47H53NO15
GëÑ95%
2850227-40-4
5+¦,10+¦-bis(acetyloxy)-13+¦-[[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy]-1,2+¦,4,7+¦-tetrahydroxy-9-oxotax-11-en-20-yl benzoate; Paclitaxel Oxetane Ring-Opened 3-Acetyl 4-Benzoyl Impurity; (1S,3R,4S,4aR,5S,6S,8S,11R,12aS)-8-(((2R,3S)- PACLITAXEL EP IMPURITY N
CAS:27548-93-2
Formula: C31H38O11
GëÑ95%
NP1766
4,10+¦-Bis(acetyloxy)-1,7+¦,13+¦-trihydroxy-9-oxo-5+¦,20-epoxytax-11-en-2+¦-yl benzoate; 13-O-de[(2R,3S)-3-Benzamido-2-hydroxy-3-phenylpropanoyl]paclitaxel; Baccatin III; 7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxet-5-one, 6,12b-bis(acetyloxy)- PACLITAXEL IMPURITY 2
CAS:959572-72-6
Formula: C33H45NO8
959572-72-6
(3S,4aR,5S,6S,11R,12R,12aR)-5-(Acetyloxy)-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-6,11,12-trihydroxy-9,12a,13,13-tetramethyl-4-methylene-8-oxo-6,10-methanobenzocyclodecen-3-yl +¦-(Dimethylamino)-benzenepropanoate PACLITAXEL N-BUTYL ANALOG
Formula: C45H55NO14
> 95%
Benzenepropanoic acid, +¦-hydroxy-+¦-[(1-oxopentyl)amino]-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyc PACLITAXEL OXETANE RING-OPENED 3-ACETYL 4-BENZOYL IMPURITY
CAS:932042-85-8
Formula: C47H53NO15
GëÑ95%
B1370-247840
Benzenepropanoic acid, +¦-(benzoylamino)-+¦-hydroxy-, (1S,3S,4S,4aR,5S,6S,8S,11R,12aS)-3,11-bis(acetyloxy)-4-[(benzoyloxy)methyl]-1,2,3,4,4a,5,6,7,8,11,12,12a-dodecahydro-1,4,5,6-tetrahydroxy-9,12a,13,13-tetramethyl-12-oxo-6,10-methanobenzocy PACLITAXEL SUCCINATE
CAS:117527-50-1
Formula: C51H55NO17
98%
117527-50-1
2'-O-Succinoylpaclitaxel; 2'-O-Succinylpaclitaxel; 2'-Succinylpaclitaxel; 2'-Succinyltaxol; Paclitaxel 2'-(Hydrogen Succinate); Paclitaxel 2'-Hemisuccinate; [2aR-[2a+¦,4+¦,4a+¦,6+¦,9+¦(1R*,2S*),11+¦,12+¦,12a+¦,12b+¦]]-Mono[2-(benzoylamino)-1-[[[6,12 Paclitaxel Succinate-[d4]
Formula: C51H51D4NO17
BLP-015226
Paclitaxel Succinate-d4; 2'-O-Succinoylpaclitaxel-d4; Paclitaxel 2'-(Hydrogen Succinate-d4); 4-(((1R,2R)-1-Benzamido-3-(((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-diacetoxy-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4 PACLITAXEL-8-HYDRO-BICYCLO(3.3.0)OCTANE
CAS:146139-03-9
Formula: C47H51NO14
93%
146139-03-9
(1R,2R,4S,5S,7R,10S,11R,12S,13S,15S,16S)-2,10-diacetyloxy-5,13-dihydroxy-4,16,17,17-tetramethyl-8-oxa-3-oxo-12-phenylcarbonyloxypentacyclo[11.3.1.01,11.04,11.07,10]heptadec-15-yl (2R,3S)-2-hydroxy-3-phenyl-3-(phenylcarbonylamino)propanoate; PAECILOQUINONE E
CAS:162797-36-6
Formula: C20H16O7
BBF-02344
2,5-Ethanoanthra[2,3-d]-1,3-dioxepin-7,12-dione, 4,5-dihydro-6,8,10-trihydroxy-2-methyl-, (1R,17R)- PAECILOQUINONE F
CAS:162797-37-7
Formula: C20H14O9
BBF-02345
2,5-Epoxyanthra[2,3-b]oxepin-5(2H)-carboxylic acid, 3,4,7,12-tetrahydro-6,8,10-trihydroxy-2-methyl-7,12-dioxo-, (1S,17R)- PAEONOLIDE
CAS:72520-92-4
Formula: C20H28O12
>98%
72520-92-4
C10715; 1-[4-methoxy-2-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxy-phenyl]ethanone; Paeonolide; 2-Acetyl-5-methoxyphenyl 6-O-(alpha-L-Arabinopyranosyl)-beta-D-glucopyranoside; 2-Ace PALBINONE
CAS:139954-00-0
Formula: C22H30O4
>98%
NP6480
18-Norandrosta-11,13(17)-diene-15,16-dione,3,17-dihydroxy-4,4,8,14-tetram
ethyl-,(3beta,5alpha)-;(3beta,5alpha,8xi,14xi)-3,17-dihydroxy-4,4,8,10,14-pentamethylgo
na-11,13(17)-diene-15,16-dione. PALBOCICLIB IMPURITY 10
CAS:2206135-30-8
Formula: C41H55N11O5
95%
B2694-338793
1-Piperazinecarboxylic acid, 4,4'-[(8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidine-2,6-diyl)bis(imino-2,5-pyridinediyl)]bis-, 1,1'-bis(1,1-dimethylethyl) ester; 1,1'-Bis(1,1-dimethylethyl) 4,4'-[(8-cyclopentyl-7,8-dihydro-5 |
